Long-term glutamate supplementation failed to protect against peripheral neurotoxicity of paclitaxel

European Journal of Cancer Care

Volumn 18, Issue 1, 2009, Pages 78-83

  Loven, D ^a   Levavi, H ^b   Sabach, G ^b   Zart, R ^b   Andras, M ^b   Fishman, A ^c   Karmon, Y ^c   Levi, T ^d   Dabby, R ^d   Gadoth, N ^e  

^a HAEMEK MEDICAL CENTER   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c MEIR MEDICAL CENTER   (Israel)

^d WOLFSON MEDICAL CENTER   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

Glutamate; Glutamine; Neurotoxicity; Paclitaxel; Peripheral neuropathy

Indexed keywords

ANTINEOPLASTIC AGENT; GLUTAMIC ACID; PACLITAXEL;

ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MIDDLE AGED; MULTICENTER STUDY; OVARY TUMOR; PERIPHERAL NEUROPATHY; RANDOMIZED CONTROLLED TRIAL; TOXICITY AND INTOXICATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DOUBLE-BLIND METHOD; FEMALE; GLUTAMIC ACID; HUMANS; MIDDLE AGED; NEUROTOXICITY SYNDROMES; OVARIAN NEOPLASMS; PACLITAXEL; PERIPHERAL NERVOUS SYSTEM DISEASES; TREATMENT OUTCOME;

EID: 58149279099     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2008.00996.x     Document Type: Article

References (14)

1. Argyriou A.A., Polychronopoulus P., Iconomou G., Koutras A., Kalofonos H.P. Chroni E. (2005) Paclitaxel plus carboplatin-induced peripheral neuropathy: a prospective clinical and electrophysiological study in patients suffering from solid malignancies. Journal of Neurology 252, 1459 1464.
2. Boyle F.M., Wheeler H.R. Shenfield G.M. (1996) Glutamate ameliorates experimental vincristine neuropathy. The Journal of Pharmacology and Experimental Therapeutics 279, 410 415.
3. Boyle F.M., Wheeler H.R. Shenfield G.M. (1999) Amelioration of experimental cisplatin and paclitaxel neuropathy with glutamate. Journal of Neuro-Oncology 41, 107 116.
4. Gilman S. (2002) Joint position sense and vibration sense: anatomical organization and assessment. Journal of Neurology, Neurosurgery, and Psychiatry 73, 473 477.
5. Her Majesty's Stationary Office (1943) Aids to the Investigation of the Peripheral Nerve Injuries. War Memorandum No. 7. Medical Research Council, London, UK.
6. Jackson D.V., Wells H.B., Atkins J.N., Zekan P.J., White D.R., Richards F., 2nd., Cruz J.M. Muss H.B. (1988) Amelioration of vincristine neurotoxicity by glutamic acid. The American Journal of Medicine 84, 1016 1022.
7. Jamieson S.M., Liu J.J., Connor B., Dragunow M. McKeage M.J. (2007) Nucleolar enlargement, nuclear eccentricity and altered cell body immunostaining characteristics of large-sized sensory neurons following treatment of rats with paclitaxel. Neurotoxicology 28, 1092 1098.
8. 2 over 3 h) employed in the treatment of gynecologic malignancies. Journal of Cancer Research and Clinical Oncology 127, 55 58.
9. Mielke S., Sparreboom A. Mross K. (2006) Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes. European Journal of Cancer 42, 24 30.
10. Newsholme P., Procopio J., Lima M.M., Pithon-Curi T.C. Curi R. (2003) Glutamine and glutamate-their central role in cell metabolism and function. Cell Biochemistry and Function 21, 1 9.
11. Rowinsky E.K., Chaudhry V., Cornblath D.R. Donehower R.C. (1993) Neurotoxicity of Taxol. Journal of the National Cancer Institute. Monographs 15, 107 115.
12. Savarese D.M., Savy G., Vadhat L., Wischmeyer P.E. Corey B. (2003) Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treatment Reviews 29, 501 513.
13. Stubblefield M.D., Vahdat L.T., Balmaceda C.M., Troxel A.B., Hesdorffer C.S. Gooch C.L. (2005) Glutamine as a neuroprotective agent in high-dose paclitaxel- induced peripheral neuropathy: a clinical and electrophysiological study. Clinical Oncology 17, 271 276.
14. Vadhat L., Papadopoulos K., Lange D., Leuin S., Kaufman E., Donovan D., Frederick D., Bagiella E., Tiersten A., Nichols G., Garrett T., Savage D., Antman K., Hesdorffer C.S. Balmaceda C. (2001) Reduction of Paclitaxel-induced peripheral neuropathy with glutamine. Clinical Cancer Research 7, 1192 1197.